Intuitive Surgical Announces $21.1 Million Final Fourth Quarter Revenue, up 32%; Gross Margin Reaches 55%

February 7, 2003 at 10:15 AM EST
SUNNYVALE, Calif., Feb 7, 2003 (BUSINESS WIRE) -- Intuitive Surgical, Inc. (Nasdaq:ISRG), the leader in operative surgical robotics, today reported sales of $21.1 million in the fourth quarter of 2002, up 32% from $16.0 million in sales reported in the fourth quarter of 2001. Higher sales were driven by continued recurring revenue growth and additional da Vinci Surgical System unit shipments. Fourth quarter 2002 recurring revenue totaled $4.7 million, up 105% over the prior year and up $0.8 million sequentially from the third quarter of 2002. Intuitive shipped 17 da Vinci Surgical Systems during the fourth quarter 2002 compared to 15 during the fourth quarter last year.

Full year 2002 sales totaled $72.0 million, up 39% from $51.7 million in 2001. Recurring revenue totaled $15.1 million in 2002, compared to $7.0 million in 2001. Intuitive shipped 60 total da Vinci Surgical Systems during fiscal 2002 compared to 49 in the previous year. The following table compares fourth quarter and fiscal year 2002 revenue to the prior year.

                             Q402   Q401  Incr.    FY02   FY01  Incr.
   Revenue ($ Millions)
   Systems                  $16.4  $13.7  $2.7    $56.9  $44.7  $12.2
   Instruments/Accys        $ 3.2  $ 1.6  $1.6    $10.1  $ 5.0  $ 5.1
   Service                  $ 1.5  $ 0.7  $0.8    $ 5.0  $ 2.0  $ 3.0
                            -----  ----- -----    -----  -----  -----
                            $21.1  $16.0  $5.1    $72.0  $51.7  $20.3
   System Population
   Placements                  17     15     2       60     49     11
   Cumulative Placements      149     89    60      149     89     60
Gross margin for the fourth quarter of 2002 was 55.0%, compared with 42.3% for the fourth quarter of 2001. Fourth quarter 2001 gross margin was negatively impacted by $1 million due to a non-routine royalty charge taken to cost of sales. Excluding the impact of this item, fourth quarter 2001 gross margin would have been 48.5%. Full year 2002 gross margin was 52.0% compared to 45.4% in 2001. Improved 2002 gross margin was driven by a higher da Vinci Surgical System average selling price and improved manufacturing efficiency.

Net loss for the fourth quarter 2002 was $2.6 million, or ($0.07) per share compared to $4.3 million, or ($0.12) per share during the fourth quarter 2001. Full year 2002 net loss was $18.4 million, or ($0.51) per share compared to $16.7 million, or ($0.47) per share in fiscal 2001.

Intuitive was cash positive during the fourth quarter 2002, ending the quarter with $50.8 million in cash, up $2.3 million from the previous quarter end.

Commenting on the announcement, Lonnie Smith, President and CEO of Intuitive Surgical said: "We are pleased with another record quarter and our improving gross margins. We continue to enjoy strong recurring revenue momentum and with our recent additional cardiac clearances, we look forward to continued growth in system sales and usage."

The company will also announce these results at a conference call today at 10:00 AM PT. The dial-in numbers for this call are 877-909-3508 for U.S. calls and 484-630-4228 for international calls. The passcode is ISRG and the meeting leader is Mr. Lonnie Smith.

About the da Vinci Surgical System:

The da Vinci Surgical System consists of a surgeon's viewing and control console having an integrated, high-performance InSite 3-D vision system, a patient-side cart consisting of three robotic arms that position and precisely maneuver endoscopic instruments and an endoscope, and a variety of articulating EndoWrist Instruments. By integrating computer-enhanced technology with surgeons' technical skills, Intuitive believes that its System enables surgeons to perform better surgery in a manner never before experienced. The da Vinci Surgical System seamlessly and directly translates the surgeon's natural hand, wrist and finger movements on instrument controls at the surgeon's console outside the patient's body into corresponding micro-movements of the instrument tips positioned inside the patient through small puncture incisions, or ports.

The statements contained in this release may be deemed to contain "forward-looking statements." Such statements are indicated by words or phrases such as "anticipate," "estimate," "projects," "believes," "intends," "expects" and similar words and phrases. Actual results may differ materially from those expressed or implied in any forward-looking statement as a result of certain risks and uncertainties, including, without limitation, competition and market acceptance of the Company's products, ability to obtain regulatory approvals and third-party reimbursement, ability to raise additional capital and other risks and uncertainties detailed in the Company's Securities and Exchange Commission filings. Prospective investors are cautioned not to place undue reliance on such forward-looking statements.

Intuitive(R), da Vinci(TM), InSite(TM), and EndoWrist(TM) are trademarks of Intuitive Surgical, Inc.

                   Intuitive Surgical, Incorporated
                 Consolidated Statements of Operations
                 (in Thousands, Except Per Share Data)
                                                  Three months ended
                                                  Dec. 31,    Dec.31,
                                                     2002       2001
Sales                                             $21,145    $16,013
Cost of sales                                       9,512      9,246
                                                  -------    -------
     Gross profit                                  11,633      6,767
Operating costs and expenses:
     Research and development                       4,026      3,791
     Selling, general and administrative           10,602      8,034
                                                  -------    -------
         Total operating costs and expenses        14,628     11,825
Loss from operations                               (2,995)    (5,058)
Interest income/(expense)                             395        806
                                                  -------    -------
Net loss                                          $(2,600)   $(4,252)
                                                  =======    =======
Weighted average shares outstanding
     used to compute net loss per share            36,641     36,147
                                                  -------    -------
Loss per share - basic and diluted                $ (0.07)   $ (0.12)
                                                  =======    =======
                   Intuitive Surgical, Incorporated
                 Consolidated Statements of Operations
                 (in Thousands, Except Per Share Data)
                                                  Fiscal year ended
                                                Dece. 31,    Dec. 31,
                                                  2002         2001
Sales                                          $ 72,022     $ 51,673
Cost of sales                                    34,584       28,218
                                                -------      -------
     Gross profit                                37,438       23,455
Operating costs and expenses:
     Research and development                    16,793       13,851
     Selling, general and administrative         40,864       29,987
                                                -------      -------
         Total operating costs and expenses      57,657       43,838
Loss from operations                            (20,219)     (20,383)
Interest income/(expense)                         1,798        3,683
                                                -------      -------
Net loss                                       $(18,421)    $(16,700)
                                                =======      =======
Weighted average shares outstanding
     used to compute net loss per share          36,458       35,815
                                                -------      -------
Loss per share - basic and diluted             $  (0.51)    $  (0.47)
                                                =======      =======
                   Intuitive Surgical, Incorporated
                      Consolidated Balance Sheets
                            (in Thousands)
                                               Dec. 31,     Dec. 31,
                                                 2002          2001 *
Assets
Current assets:
   Cash, cash equivalents and short-term
    investments                               $  50,839     $  66,661
   Accounts receivable, net                      16,887        13,248
   Inventories, net                               8,738         6,182
   Prepaid expenses                               2,161         3,128
                                                -------       -------
     Total current assets                        78,625        89,219
Property and equipment, net                      10,388         7,834
Other assets                                      2,568         3,308
                                                -------       -------
Total assets                                  $  91,581     $ 100,361
                                                =======       =======
Liabilities and stockholders' equity
Current Liabilities:
   Accounts payable                           $   9,282     $   8,300
   Accrued compensation and employee benefits     4,666         2,537
   Warranty provision                             2,269         1,831
   Accrued Royalty                                   --         1,000
   Accrued liabilities                            3,497         2,128
   Deferred revenue                               4,838         3,870
   Current portion of notes payable               1,511         1,631
                                                -------       -------
     Total current liabilities                   26,063        21,297
Notes payable                                     1,838           771
Stockholders' equity
   Common stock                                      36            36
   Additional paid-in capital                   191,020       188,962
   Deferred compensation                           (223)         (886)
   Accumulated deficit                         (128,791)     (110,370)
   Accumulated other comprehensive income         1,638           551
                                                -------       -------
     Total stockholders' equity                  63,680        78,293
Total liabilities and stockholders' equity    $  91,581     $ 100,361
                                                =======       =======
*   Derived from the audited financial statements included in our
    annual report on form 10K for the fiscal year ended December 31,
    2001 but does not include all of the information and footnotes
    required by accounting principles generally accepted in the United
    States for complete financial statements.

CONTACT: Intuitive Surgical, Inc. Ben Gong, 408/523-2175 Sarah Norton, 650/523-2161